AAAAAA
Results: 1-25/36
Authors:
Day, AS
Jones, NL
Policova, Z
Jennings, HA
Yau, EK
Shannon, P
Neumann, AW
Sherman, PM
Citation: As. Day et al., Characterization of virulence factors of mouse-adapted Helicobacter pyloristrain SS1 and effects on gastric hydrophobicity, DIG DIS SCI, 46(9), 2001, pp. 1943-1951
Authors:
Gold, BD
van Doorn, LJ
Guarner, J
Owens, M
Pierce-Smith, D
Song, QS
Hutwagner, L
Sherman, PM
de Mola, OL
Czinn, SJ
Citation: Bd. Gold et al., Genotypic, clinical, and demographic characteristics of children infected with Helicobacter pylori, J CLIN MICR, 39(4), 2001, pp. 1348-1352
Authors:
Sherman, PM
Sanders, TG
Morrison, WB
Schweitzer, ME
Leis, HT
Nusser, CA
Citation: Pm. Sherman et al., MR imaging of the posterior cruciate ligament graft: Initial experience in15 patients with clinical correlation, RADIOLOGY, 221(1), 2001, pp. 191-198
Approaching Helicobacter pylori infection in children: Level I evidence atlast and a word of caution
Authors:
Jones, NL
Sherman, PM
Citation: Nl. Jones et Pm. Sherman, Approaching Helicobacter pylori infection in children: Level I evidence atlast and a word of caution, J PEDIAT, 139(5), 2001, pp. 622-623
Authors:
Johnson-Henry, K
Wallace, JL
Basappa, NS
Soni, R
Wu, GKP
Sherman, PM
Citation: K. Johnson-henry et al., Inhibition of attaching and effacing lesion formation following enteropathogenic Escherichia coli and Shiga toxin-producing E-coli infection, INFEC IMMUN, 69(11), 2001, pp. 7152-7158
Authors:
Zareie, M
Singh, PK
Irvine, EJ
Sherman, PM
McKay, DM
Perdue, MH
Citation: M. Zareie et al., Monocyte/macrophage activation by normal bacteria and bacterial products -Implications for altered epithelial function in Crohn's disease, AM J PATH, 158(3), 2001, pp. 1101-1109
Authors:
Hunt, RH
SMaill, FM
Fallone, CA
Sherman, PM
van Zanten, SJV
Thomson, ABR
Citation: Rh. Hunt et al., Implications of antibiotic resistance in the management of Helicobacter pylori infection: Canadian Helicobacter Study Group, CAN J GASTR, 14(10), 2000, pp. 862-868
Authors:
Gold, BD
Colletti, RB
Abbott, M
Czinn, SJ
Elitsur, Y
Hassall, E
Macarthur, C
Snyder, J
Sherman, PM
Citation: Bd. Gold et al., Helicobacter pylori infection in children: Recommendations for diagnosis and treatment, J PED GASTR, 31(5), 2000, pp. 490-497
Authors:
Sherman, PM
Citation: Pm. Sherman, A charter of rights for children, parents and families seen and cared for by pediatric gastroenterologists, J PED GASTR, 31(2), 2000, pp. 100-101
Authors:
Sherman, PM
Citation: Pm. Sherman, Should performance of diagnostic procedures in pediatric gastroenterology be limited to pediatric gastroenterologists?, J PED GASTR, 30(5), 2000, pp. 475-476
Authors:
Laxer, RM
Sherman, PM
Citation: Rm. Laxer et Pm. Sherman, Subspecialty clinics require evidence of efficacy, J PED GASTR, 30(5), 2000, pp. 475-475
Authors:
Sherman, PM
Citation: Pm. Sherman, Emerging role of the enteric nervous system in mediating host responses tomicrobial infections, J PED GASTR, 30(3), 2000, pp. 229-230
Authors:
Jones, NL
Islur, A
Haq, R
Mascarenhas, M
Karmali, MA
Perdue, MH
Zanke, BW
Sherman, PM
Citation: Nl. Jones et al., Escherichia coli Shiga toxins induce apoptosis in epithelial cells that isregulated by the Bcl-2 family, AM J P-GAST, 278(5), 2000, pp. G811-G819
Authors:
Day, AS
Sherman, PM
Citation: As. Day et Pm. Sherman, Helicobacter pylori infection, host genes, and disease outcome, PEDIAT RES, 47(6), 2000, pp. 703-703
Authors:
Day, AS
Jones, NL
Lynett, JT
Jennings, HA
Fallone, CA
Beech, R
Sherman, PM
Citation: As. Day et al., cagE is a virulence factor associated with Helicobacter pylori-induced duodenal ulceration in children, J INFEC DIS, 181(4), 2000, pp. 1370-1375
Authors:
Foster, DB
Philpott, D
Abul-Milh, M
Huesca, M
Sherman, PM
Lingwood, CA
Citation: Db. Foster et al., Phosphatidylethanolamine recognition promotes enteropathogenic E-coli and enterohemorrhagic E-coli host cell attachment, MICROB PATH, 27(5), 1999, pp. 289-301
Authors:
Jones, NL
Sherman, PM
Citation: Nl. Jones et Pm. Sherman, Helicobacter pylori-epithelial cell interactions: From adhesion to apoptosis, CAN J GASTR, 13(7), 1999, pp. 563-566
Authors:
Jones, NL
Day, AS
Sherman, PM
Citation: Nl. Jones et al., Determinants of disease outcome following Helicobacter pylori infection inchildren, CAN J GASTR, 13(7), 1999, pp. 613-617
Authors:
Sherman, PM
Craitoru, K
Citation: Pm. Sherman et K. Craitoru, Pathobiology of Helicobacter pylori infection, CAN J GASTR, 13(3), 1999, pp. 212-212
Understanding disease outcome following acquisition of Helicobacter pyloriinfection during childhood
Authors:
Day, AS
Sherman, PM
Citation: As. Day et Pm. Sherman, Understanding disease outcome following acquisition of Helicobacter pyloriinfection during childhood, CAN J GASTR, 13(3), 1999, pp. 229-234
Authors:
Sherman, PM
Citation: Pm. Sherman, New drugs for use in inflammatory bowel diseases: Just over the horizon, J PED GASTR, 29(5), 1999, pp. 530-531
Authors:
Sherman, PM
Citation: Pm. Sherman, Research training for pediatric gastroenterologists, J PED GASTR, 29(5), 1999, pp. 531-531
Authors:
Sherman, PM
Citation: Pm. Sherman, Novel strategies for preventing diarrheal diseases, J PED GASTR, 29(3), 1999, pp. 238-239
Authors:
Griffiths, AM
Nicholas, D
Smith, C
Munk, M
Stephens, D
Durno, C
Sherman, PM
Citation: Am. Griffiths et al., Development of a quality-of-life index for pediatric inflammatory bowel disease: Dealing with differences related to age and IBD type, J PED GASTR, 28(4), 1999, pp. S46-S52
Authors:
Jones, NL
Sherman, PM
Citation: Nl. Jones et Pm. Sherman, The mechanism underlying aspirin's anti-inflammatory effects: A new twist to an old tale, J PED GASTR, 28(3), 1999, pp. 239-239